Company
Ferring Pharms INC
Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.gov
NDAs and BLAs
23
10 still marketed
Novel approvals
4
Approvals since 2021
0
Originals and new uses
Phase 3 trials
0
Registered, any status
Trials by phase
All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.
Recent approvals
Originals and efficacy supplements, newest first.
Drugs in development (0)
Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.
No investigational drugs in Phase 2 or 3 trials under this sponsor name.
Recruiting Phase 3 trials
Largest first.
No recruiting Phase 3 trials under this sponsor name.
Marketed drugs (10)
Newest FDA action first.
- Endometrin Progesterone · 2007
- Zomacton Somatropin · 1995
- Clenpiq Citric Acid, Magnesium Oxide, Sodium Picosulfate · 2017
- Chorionic Gonadotropin Gonadotropin, Chorionic · 1974
- Cervidil Dinoprostone · 1995
- Firmagon Degarelix Acetate · 2008
- Menopur Menotropins (Fsh, Lh) · 2004
- Acthrel Corticorelin Ovine Triflutate · 1996
- Ddavp Desmopressin Acetate · 1995
- Bravelle Urofollitropin · 2002
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.